These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8940975)

  • 1. Short report: long-term serum antibody isotype responses to Strongyloides stercoralis filariform antigens in eight patients treated with ivermectin.
    Lindo JF; Atkins NS; Lee MG; Robinson RD; Bundy DA
    Am J Trop Med Hyg; 1996 Nov; 55(5):474-6. PubMed ID: 8940975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of a high level of specific IgG4 antibody associated with resistance to albendazole treatment in HLA-DRB1*0901-positive patients with strongyloidiasis.
    Satoh M; Toma H; Sato Y; Kikuchi M; Takara M; Shiroma Y; Kiyuna S; Hirayama K
    Am J Trop Med Hyg; 1999 Oct; 61(4):668-71. PubMed ID: 10548308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a sex-related difference of Strongyloides stercoralis-specific IgG4 antibody titer with the efficacy of treatment of strongyloidiasis.
    Satoh M; Toma H; Kiyuna S; Shiroma Y; Kokaze A; Sato Y
    Am J Trop Med Hyg; 2004 Jul; 71(1):107-11. PubMed ID: 15238698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report:
    De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM
    Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207
    [No Abstract]   [Full Text] [Related]  

  • 5. Parasite-specific serum IgG following successful treatment of endemic strongyloidiasis using ivermectin.
    Lindo JF; Atkins NS; Lee MG; Robinson RD; Bundy DA
    Trans R Soc Trop Med Hyg; 1996; 90(6):702-3. PubMed ID: 9015524
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic accuracy of a novel enzyme-linked immunoassay for the detection of IgG and IgG4 against Strongyloides stercoralis based on the recombinant antigens NIE/SsIR.
    Tamarozzi F; Longoni SS; Mazzi C; Pettene S; Montresor A; Mahanty S; Bisoffi Z; Buonfrate D
    Parasit Vectors; 2021 Aug; 14(1):412. PubMed ID: 34407876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of concurrent HTLV-I infection in strongyloidiasis.
    Atkins NS; Lindo JF; Lee MG; Hanchard B; Robinson RD; Bundy DA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):188-90. PubMed ID: 9637586
    [No Abstract]   [Full Text] [Related]  

  • 8. Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection.
    Higashiarakawa M; Hirata T; Tanaka T; Parrott G; Kinjo T; Naka H; Hokama A; Fujita J
    Parasitol Int; 2017 Feb; 66(1):807-812. PubMed ID: 27744050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total serum IgE and parasite-specific IgG and IgA antibodies in human strongyloidiasis.
    Rossi CL; Takahashi EE; Partel CD; Teodoro LG; da Silva LJ
    Rev Inst Med Trop Sao Paulo; 1993; 35(4):361-5. PubMed ID: 8115797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
    Satoh M; Toma H; Sato Y; Takara M; Shiroma Y; Kiyuna S; Hirayama K
    Clin Exp Immunol; 2002 Feb; 127(2):354-9. PubMed ID: 11876761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial.
    Buonfrate D; Salas-Coronas J; Muñoz J; Maruri BT; Rodari P; Castelli F; Zammarchi L; Bianchi L; Gobbi F; Cabezas-Fernández T; Requena-Mendez A; Godbole G; Silva R; Romero M; Chiodini PL; Bisoffi Z
    Lancet Infect Dis; 2019 Nov; 19(11):1181-1190. PubMed ID: 31558376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.
    Pacanowski J; Santos MD; Roux A; LE Maignan C; Guillot J; Lavarde V; Cornet M
    Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L3 antigen-specific antibody isotype responses in human strongyloidiasis: correlations with larval output.
    Atkins NS; Conway DJ; Lindo JF; Bailey JW; Bundy DA
    Parasite Immunol; 1999 Oct; 21(10):517-26. PubMed ID: 10587378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An overview of Strongyloides stercoralis and its infections].
    Ardiç N
    Mikrobiyol Bul; 2009 Jan; 43(1):169-77. PubMed ID: 19334396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG1, IgG4, and IgE antibody responses in human strongyloidiasis by ELISA using Strongyloides ratti saline extract as heterologous antigen.
    Rodrigues RM; de Oliveira MC; Sopelete MC; Silva DA; Campos DM; Taketomi EA; Costa-Cruz JM
    Parasitol Res; 2007 Oct; 101(5):1209-14. PubMed ID: 17610082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific IgA and IgG antibodies in paired serum and breast milk samples in human strongyloidiasis.
    Mota-Ferreira DM; Gonçalves-Pires Mdo R; Júnior AF; Sopelete MC; Abdallah VO; Costa-Cruz JM
    Acta Trop; 2009 Feb; 109(2):103-7. PubMed ID: 19007741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012.
    Valerio L; Roure S; Fernández-Rivas G; Basile L; Martínez-Cuevas O; Ballesteros ÁL; Ramos X; Sabrià M;
    Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):465-70. PubMed ID: 23783760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of dried blood spots to define antibody response to the Strongyloides stercoralis recombinant antigen NIE.
    Mounsey K; Kearns T; Rampton M; Llewellyn S; King M; Holt D; Currie BJ; Andrews R; Nutman T; McCarthy J
    Acta Trop; 2014 Oct; 138():78-82. PubMed ID: 25051188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strongyloides stercoralis hyperinfection in a patient with AIDS in Uganda successfully treated with ivermectin.
    Orem J; Mayanja B; Okongo M; Morgan D
    Clin Infect Dis; 2003 Jul; 37(1):152-3. PubMed ID: 12830426
    [No Abstract]   [Full Text] [Related]  

  • 20. Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis.
    Karunajeewa H; Kelly H; Leslie D; Leydon J; Saykao P; Biggs BA
    J Travel Med; 2006; 13(2):84-91. PubMed ID: 16553594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.